Replies to post #136924 on Bioelectronics Corp (BIEL)

[speakhim]

Where was share structure then, what would that equal today? Thank you

[Simpsonly]

I recall that est I100. I think you can quite reasonably make that 3 to 10 cents now, which ends the stupid diatribe about the number of shares now. Only those who don't understand how the company issued shares in order to finance the journey will continue to spew that nonsense.It's simply how we got this far.

That 2009 30 to 50 est. did not take into account the escalation of the opioid and pain drug pandemic OR >50 countries OTC, the UK NHS, actually the 4 countries forming GB, plus B. Braun, Migraines, Allay - that 30 to 50 cents was very early days and many were estimating higher. I suggest a higher number may be in order to recognize the current magnitude of the ActiPatch potential.

BIEL . . . . Tsunami . . . . imminent

[Investor100]

Historical Perspective @ BIEL (2009)

There was much to be proud back in 2009 with this distinguished award given to Biel on product innovation by Wall Street Journal. In great company if you look at the guest speaker ( Mark Benioff of Salesforce)

I have been here since 2009 - I know what I own, use the product for my back and shoulder successfully, and believe that better days, weeks, months and years ahead for this company. Own it not trade it!


BioElectronics Wins Wall Street Journal 2009 Innovation Award

FREDERICK, MD -- (Marketwire) -- 09/14/09 -- BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced it has been selected as a runner up in the medical device category of the 2009 Wall Street Journal Innovation Awards unveiled in today's global editions and online. The award was given for the Company's wearable patch that uses pulsed electromagnetic energy to deliver drug-free pain relief for a variety of conditions.

Richard Staelin, Chairman of the Board of BioElectronics, said, "We are gratified that such a prestigious organization has validated the work of BioElectronics management to bring our innovative technology to market.

For a start-up of our size, it is exciting to be on a winners list that includes this year established technology leaders like Abbot Labs, HP, Qualcomm, National Semiconductor, Intel and NASA. The Wall Street Journal said that they received almost 500 nominations from around the world and selected only 36 winners." A complete file of this year's winners is available on the WSJ Online website or on http://www.healfasttherapy.com/wsjinnovationaward.

Andrew Whelan, BioElectronics CEO, will accept the award at The Wall Street Journal's 2009 Technology Innovation Awards ceremony on Oct. 13 at a dinner in Redwood City, Calif. featuring a keynote address by Marc Benioff, chairman and chief executive of Salesforce.com Inc. The ceremony will be held in conjunction with the Dow Jones VentureWire Technology Showcase.

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch® Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com ) and the Allay(TM) family (www.AllayPatch.com) of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1062604